ConductScience.org, home

Paper42192576

The Prophylactic Effect of Dexmedetomidine 0.008% Versus Brimonidine 0.2% on IOP Elevation After Nd: YAG Laser Capsulotomy.

Zakeri P and 3 others. Pharmacol Res Perspect, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. The Prophylactic Effect of Dexmedetomidine 0.008% Versus Brimonidine 0.2% on IOP Elevation After Nd: YAG Laser Capsulotomy. Papers, record 42192576. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42192576

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Prophylactic Effect of Dexmedetomidine 0.008% Versus Brimonidine 0.2% on IOP Elevation After Nd: YAG Laser Capsulotomy.
PubMed
Journal
Pharmacol Res Perspect
PubMed
Year
2026
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Comparative Study
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-22
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zakeri PParisa
2Akhavanakbari GGhodrat
3Ojaghi HHabib
4Amani FFirouz

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DexmedetomidineMajor topic
Brimonidine TartrateMajor topic
Intraocular PressureMajor topic
Posterior CapsulotomyMajor topic
Humans
Female
Double-Blind Method
Prospective Studies
Male
Ophthalmic Solutions
Aged
Lasers, Solid-State
Capsule Opacification
Adrenergic alpha-2 Receptor Agonists
Postoperative Complications

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Ardabil University of Medical SciencesPubMed

Source PubMed

Download CSV of grants

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125885718Efficacy and safety of dexmedetomidine as an additive to local anesthetics in peribulbar block for cataract surgery.Anesth Essays Res2013https://conductscience.org/library/papers/25885718PubMed
233595486Effect of dexmedetomidine on intraocular pressure as an additive in peribulbar block during glaucoma surgery.Indian J Ophthalmol2021https://conductscience.org/library/papers/33595486PubMed
320236252Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.Acta Ophthalmol2011https://conductscience.org/library/papers/20236252PubMed
428261613The Effects of Intravenous Dexmedetomidine Injections on IOP in General Anesthesia Intubation: A Meta-Analysis.Biomed Res Int2017https://conductscience.org/library/papers/28261613PubMed
512658557Dorzolamide X apraclonidine in the prevention of the intraocular pressure spike after Nd : YAG laser posterior capsulotomy.Curr Eye Res2002https://conductscience.org/library/papers/12658557PubMed
616931262Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.J Cataract Refract Surg2006https://conductscience.org/library/papers/16931262PubMed
724205938Benzalkonium chloride and glaucoma.J Ocul Pharmacol Ther2014https://conductscience.org/library/papers/24205938PubMed
834753412The prophylactic effect of betaxolol 0.5% versus brimonidine 0.2% on IOP elevation after Nd:YAG laser posterior capsulotomy.Clin Exp Optom2022https://conductscience.org/library/papers/34753412PubMed
932944557Dexmedetomidine as an Additive to Local Anesthesia for Decreasing Intraocular Pressure in Glaucoma Surgery: A Randomized Trial.Anesth Pain Med2020https://conductscience.org/library/papers/32944557PubMed
1032247310Perioperative Dexmedetomidine for outpatient cataract surgery: a systematic review.BMC Anesthesiol2020https://conductscience.org/library/papers/32247310PubMed
1138623708Understanding the treatment paradigm and the sequencing of antiglaucoma fixed-dose combinations in a tertiary center in South India.Indian J Ophthalmol2024https://conductscience.org/library/papers/38623708PubMed
1216808678Brimonidine 0.2% versus brimonidine Purite 0.15%: prophylactic effect on iop elevation after Nd:YAG laser posterior capsulotomy.J Ocul Pharmacol Ther2006https://conductscience.org/library/papers/16808678PubMed
1332740512Effect of Intravenous Dexmedetomidine on Intraocular Pressure in Patients Undergoing Glaucoma Surgery Under Local Anesthesia: A Pilot Study.J Glaucoma2020https://conductscience.org/library/papers/32740512PubMed
1429284835
To Evaluate the Efficacy of Intravenous Infusion of Dexmedetomidine as Premedication in Attenuating the Rise of Intraocular Pressure Caused by Succinylcholine in Patients Undergoing Rapid Sequence Induction for General Anesthesia: A Randomized Study.
Anesth Essays Res2017https://conductscience.org/library/papers/29284835PubMed
1534720494Effect of Topical Dexmedetomidine (0.0055%) on Intraocular Pressure in Healthy Eyes: A Randomized Controlled Trial.J Curr Glaucoma Pract2021https://conductscience.org/library/papers/34720494PubMed
1628924341Intraocular Pressure Spikes following Neodymium-doped Yttrium Aluminum Garnet Laser Capsulotomy: Current Prevalence and Management in Israel.J Curr Glaucoma Pract2017https://conductscience.org/library/papers/28924341PubMed
1739033834Efficacy of Dexmedetomidine as an Adjuvant to Local Anesthetics in Peribulbar Block: A Meta-analysis With Trial-Sequential Analysis.Am J Ophthalmol2025https://conductscience.org/library/papers/39033834PubMed
1817585375Prophylactic use of timolol maleate to prevent intraocular pressure elevation after Nd-YAG laser posterior capsulotomy.Int Ophthalmol2008https://conductscience.org/library/papers/17585375PubMed
1939021405Effects of intramuscular alfaxalone and dexmedetomidine alone and combined on ocular, electroretinographic, and cardiorespiratory parameters in normal cats.Front Vet Sci2024https://conductscience.org/library/papers/39021405PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42192576

GET https://conductscience.org/api/papers/v1/42192576/authors